A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Article number | e60094 |
| Journal | P L o S One |
| Volume | 8 |
| Issue number | 3 |
| Number of pages | 12 |
| ISSN | 1932-6203 |
| DOIs | |
| Publication status | Published - 2013 |
ID: 120017036